Recent Updates
Recently added Catalysts
ICLR

ICON plc: Purchase of Own Securities Further to the announcement on 22 November, 2011 of a share repurchase programme, ICON plc ("the Company") announces that on 23 November, 2011 it purchased for cancellation 3,810 Ordi

Friday, November 25, 2011 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: ICON plc: Purchase of Own Securities Further to the announcement on 22 November, 2011 of a share repurchase programme, ICON plc ("the Company") announces that on 23 November, 2011 it purchased for cancellation 3,810 Ordinary Shares, at an average price Following the cancellat

Full Press Release Details

ICON plc: Purchase of Own Securities
Further to the announcement on 22 November, 2011 of a share repurchase
programme, ICON plc ("the Company") announces that on 23 November, 2011
it purchased for cancellation 3,810 Ordinary Shares, at an average price
Following the cancellation of these shares, the Company will have
60,497,270 Ordinary Shares in issue.
ShareAdd on Google
Tags: ICLR Viatris Investor Conferences Healthcare investor conferences healthcare conferences UBS Global Healthcare
Last updated: Nov 25, 2011

Biotech snapshot

Lead asset
VehiclePhase 3
Alopecia, Androgenetic →